| Literature DB >> 22365944 |
Elga Fabia Belligni1, Eleonora Di Gregorio, Elisa Biamino, Alessandro Calcia, Cristina Molinatto, Flavia Talarico, Giovanni Battista Ferrero, Alfredo Brusco, Margherita Cirillo Silengo.
Abstract
We report a patient with a moderate mental retardation, afebrile seizure, mild dysmorphic features and type 2 diabetes mellitus with mild obesity and metabolic syndrome. Array-CGH analysis revealed a de novo 790-830 kb duplication on chromosome 17p13.1, not reported so far. Among the approximately 50 genes involved in the rearrangement, neuroligin 2 (NLGN2) and ephrin B3 (EFNB3) are candidates for the mental retardation phenotype. NLGN2 may therefore be a novel candidate gene for mental retardation or autistic spectrum disorder, joining other members of the neurexin/neuroligin network. Moreover, GLUT4, a member of the solute carrier family 2, may play a role in the patient's type 2 diabetes.Entities:
Mesh:
Year: 2012 PMID: 22365944 DOI: 10.1016/j.ejmg.2012.01.016
Source DB: PubMed Journal: Eur J Med Genet ISSN: 1769-7212 Impact factor: 2.708